温州医科大学学报
溫州醫科大學學報
온주의과대학학보
Journal of Wenzhou Medical University
2014年
6期
395-400
,共6页
冯燕%朱珊丽%林晓云%薛向阳%李文姝%张丽芳
馮燕%硃珊麗%林曉雲%薛嚮暘%李文姝%張麗芳
풍연%주산려%림효운%설향양%리문주%장려방
沙眼衣原体%Tarp蛋白%B细胞表位%小鼠
沙眼衣原體%Tarp蛋白%B細胞錶位%小鼠
사안의원체%Tarp단백%B세포표위%소서
Chlamydia trachomatis%translocated actin-recruiting phosphoprotein (Tarp)%B-cell epitope%mice
目的:预测并鉴定沙眼衣原体(Ct)Tarp蛋白的B细胞表位,为进一步研究Tarp蛋白的生物学特性及表位疫苗研制奠定基础。方法:利用生物信息学软件综合分析、预测筛选E血清型CtTarp蛋白的B细胞表位,获得6个潜在目的表位。将人工合成的表位肽段与弗氏佐剂充分乳化,经背部皮下多点注射途径免疫BALB/c小鼠(每次100μg/只,3只/组,共24只),间隔2周,共免疫3次。采用ELISA法检测免疫小鼠血清中Tarp蛋白特异性抗体IgG及其亚类IgG1、IgG2a,以及阴道分泌物中Tarp蛋白特异性sIgA抗体;进一步采用间接免疫荧光实验、免疫沉淀实验和Westernblot法检测表位免疫的血清抗体与Tarp蛋白结合的特异性。结果:筛选并鉴定了Tarp蛋白的一个免疫优势B细胞表位(aa171-186),该表位可以刺激小鼠产生较高水平的Tarp蛋白特异性IgG抗体和sIgA抗体,且抗体亚类以IgG1为主。免疫荧光实验、免疫沉淀实验和Westernblot法检测结果显示,该段表位肽免疫血清抗体可特异性识别Tarp蛋白。结论:获得了CtTarp蛋白的一个免疫优势B细胞表位,为进一步研究Tarp蛋白的生物学特性及表位疫苗研制奠定基础。
目的:預測併鑒定沙眼衣原體(Ct)Tarp蛋白的B細胞錶位,為進一步研究Tarp蛋白的生物學特性及錶位疫苗研製奠定基礎。方法:利用生物信息學軟件綜閤分析、預測篩選E血清型CtTarp蛋白的B細胞錶位,穫得6箇潛在目的錶位。將人工閤成的錶位肽段與弗氏佐劑充分乳化,經揹部皮下多點註射途徑免疫BALB/c小鼠(每次100μg/隻,3隻/組,共24隻),間隔2週,共免疫3次。採用ELISA法檢測免疫小鼠血清中Tarp蛋白特異性抗體IgG及其亞類IgG1、IgG2a,以及陰道分泌物中Tarp蛋白特異性sIgA抗體;進一步採用間接免疫熒光實驗、免疫沉澱實驗和Westernblot法檢測錶位免疫的血清抗體與Tarp蛋白結閤的特異性。結果:篩選併鑒定瞭Tarp蛋白的一箇免疫優勢B細胞錶位(aa171-186),該錶位可以刺激小鼠產生較高水平的Tarp蛋白特異性IgG抗體和sIgA抗體,且抗體亞類以IgG1為主。免疫熒光實驗、免疫沉澱實驗和Westernblot法檢測結果顯示,該段錶位肽免疫血清抗體可特異性識彆Tarp蛋白。結論:穫得瞭CtTarp蛋白的一箇免疫優勢B細胞錶位,為進一步研究Tarp蛋白的生物學特性及錶位疫苗研製奠定基礎。
목적:예측병감정사안의원체(Ct)Tarp단백적B세포표위,위진일보연구Tarp단백적생물학특성급표위역묘연제전정기출。방법:이용생물신식학연건종합분석、예측사선E혈청형CtTarp단백적B세포표위,획득6개잠재목적표위。장인공합성적표위태단여불씨좌제충분유화,경배부피하다점주사도경면역BALB/c소서(매차100μg/지,3지/조,공24지),간격2주,공면역3차。채용ELISA법검측면역소서혈청중Tarp단백특이성항체IgG급기아류IgG1、IgG2a,이급음도분비물중Tarp단백특이성sIgA항체;진일보채용간접면역형광실험、면역침정실험화Westernblot법검측표위면역적혈청항체여Tarp단백결합적특이성。결과:사선병감정료Tarp단백적일개면역우세B세포표위(aa171-186),해표위가이자격소서산생교고수평적Tarp단백특이성IgG항체화sIgA항체,차항체아류이IgG1위주。면역형광실험、면역침정실험화Westernblot법검측결과현시,해단표위태면역혈청항체가특이성식별Tarp단백。결론:획득료CtTarp단백적일개면역우세B세포표위,위진일보연구Tarp단백적생물학특성급표위역묘연제전정기출。
Objective: To predict and identify the B-cell epitope ofChlamydia trachomatis Tarp.Methods:The amino acid sequence of Tarp was analyzed using computer-assisted techniques to scan B-cell epitopes, and 6 possible linear B-cell epitopes peptides (aa80-95, aa107-123, aa152-170, aa171-186, aa239-253 and aa497-513) with high predicted antigenicity and high conservation were investigated. After coupling to KLH, the syn-thetic peptides were emulsiifeld with Freund’s adjuvant. Then, BALB/c mice were randomly assigned to receive (subcutaneous injection) peptides-KLH, KLH or PBS (n=3, 100 μg/time/mouse), respectively, and the same immunization schedule was repeated third times at a 2-week interval. ELISA was used to detect the IgG and sub-types IgG1, IgG2a in the serum as well as the sIgA in the vaginal secretions. Furthermore, the speciifc binding of anti-sera produced by epitopes immunization to natural Tarp antigen was detected with indirect immunolfuo-rescence assay (IFA), immunoprecipitated and Western blot analysis, respectively.Results: The epitope peptide F4 (aa171-186) was able to induce signiifcant Tarp speciifc antibody IgG in serum and sIgA in vaginal wash as compared with KLH or PBS (1:100) (P<0.05), and the major IgG antibody subtype was IgG1. Western blot and IFA results conifrmed that speciifc antibodies were induced by epitope aa171-186 recognized natural Tarp anti-gen.Conclusion: Our results demonstrated that the predictive epitopes (aa171-186) are immunodominant B-cell epitope of Tarp, and if proven protective and safe, in conjunction with others well-documented epitopes, they may be included into a candidate epitope-based vaccine.